All Type of News
Prior notice to compete between Samsung and LG over ‘bio-pharma’ field
LG Group decided to jump into the biopharmaceutical business. With Samsung Group which started large investments in the field, thus, the biopharmaceutical field is, too, expected to become an arena for large companies...
KOSPI and KOSDAQ listed pharmas had more than 10% growths in sales
The KOSPI and KOSDAQ listed pharmaceutical companies’ average collective sales were increased by more than 10% in the 3rd quarter compared to the same quarter of the last year. On the other hand, their 3rd quarter’s s...
AI vs. Pharmacist should be differentiated with ‘empathic ability’
Although professionalism of pharmacist has been stressed, an anticipation was made that the job of ‘pharmacist’ will disappear in the future since the role to dispense drugs might be replaced to the artificial intelli...
Why Korean pharma industry lacks in acquiring new drug approvals?
It was criticized the pharmaceutical industry lacks in new drug development as only having one drug developed by Korean pharmaceutical companies this year.
While there were 5 new drugs developed last year, ‘Olita Tab...
Hanmi’s ‘Olita Tab’ issue lead bill to tighten safety of clinical trial
While Hanmi Pharm’s Olita Tab encounter side effects of death during a clinical trial and is still causing issues, a bill to tighten safety of clinical trial was tabled.
On the 25th, The Minjoo Party Rep. Jung Park a...
KOSDAQ records 3 times higher than KOSPI in collective operating profits
The KOSDAQ listed pharmaceutical companies’ average collective operating profit rate this year was 3 times higher than the one of KOSPI listed pharmaceutical companies.
According to the Yakup Shinmoon’s(www.yakup.com...
Listed pharmas with increase in net profit
The KOSDAQ listed pharmaceutical companies’ collective net profit ratio against sales was 3 times higher than the one of listed pharmaceutical companies in the KOSPI market. Their average growth rate was 6 times highe...
“Medicine is not Go(game)… AI can be an assistance knowing medical terms.”
After Gil Medical Center implemented an artificial intelligence(AI) system, Watson, for the first time in Korea, several university hospitals have started to review adopting it with rosy hope.
However, an argument w...
Nature Cell acquires approval of Phase 1/2 clinical trials for dementia treatment from US FDA
Clinical trials to treat American Alzheimer’s disease patients with stem cells manufactured in Korea were approved by the U.S. FDA.
Nature Cell(CEO Jung-Chan La) announced it acquired approval of the Astrostem’s Phas...
Dong-A ST’s partnership with GSK ends on November
Dong-A ST made a notice on the 24th that the strategic partnership, which was made on May 2010 when they were Dong-A Pharm, to jointly sell the products of GlaxoSmithKline(GSK) with GSK will end on November 30, 2016. ...
